US Heart Valve Replacement Devices Market - Size, Share, Segmentation, Regional Insights, Key Players & Forecast, 2026–2035

The US Heart Valve Replacement Devices Market was valued at approximately USD 6.48 billion in 2025 and is projected to reach nearly USD 12.96 billion by 2035, expanding at a CAGR of 7.18% during the forecast period 2026–2035. Historical analysis has been conducted from 2022 to 2024, with 2025 as the base year.

Heart valve replacement procedures represent a critical component of structural heart disease management in the United States. The increasing prevalence of aortic stenosis, mitral valve disease, and congenital valve disorders, coupled with a rapidly aging population, continues to drive demand for both surgical and transcatheter replacement technologies.

Aortic stenosis remains the most prevalent severe valvular condition among older Americans. It is estimated that over 1.5 million people in the United States suffer from aortic stenosis, with approximately 300,000 cases classified as severe. Transcatheter Aortic Valve Replacement (TAVR) has significantly transformed the treatment paradigm, expanding access to low-risk and intermediate-risk patient populations.

The US healthcare system’s advanced cardiovascular infrastructure, high concentration of hybrid operating rooms, and robust Medicare reimbursement framework position the country as the global leader in heart valve replacement technology adoption and innovation.

Introduction

According to the US Heart Valve Replacement Devices Market Report, this segment is shaped by rapid technological innovation, expanding procedural indications, and evolving patient demographics. In the United States, cardiovascular disease remains the leading cause of mortality, accounting for nearly 1 in every 5 deaths annually. Structural valve disorders represent a growing burden within this broader cardiovascular landscape.

Heart valve replacement involves substituting a diseased native valve with a prosthetic mechanical or bioprosthetic device, either via open-heart surgery or minimally invasive transcatheter approaches. Replacement is typically indicated in severe stenosis or regurgitation where repair is not feasible.

The US benefits from over 1,100 hospitals equipped with advanced cardiac surgery programs, and more than 700 centers performing TAVR procedures. Academic institutions in states such as California, New York, Texas, Massachusetts, and Illinois serve as innovation hubs for next-generation valve technologies.

FDA approvals, CMS coverage determinations, and strong private payer participation ensure procedural accessibility across demographics. As longevity increases and diagnostic imaging improves early detection, demand for replacement therapies continues to rise steadily.

Key Market Drivers: What’s Fueling the US Heart Valve Replacement Devices Market Growth?

• Aging Population and Degenerative Valve Disease
  The US population aged 65 and older is projected to exceed 77 million by 2035. Degenerative calcific aortic stenosis and mitral valve degeneration are strongly age-associated conditions, making demographic aging a primary growth driver.
• Expansion of Transcatheter Valve Technologies
  Transcatheter approaches, especially TAVR, have expanded into low-risk patient populations. TMVR technologies are also progressing rapidly in clinical trials across major US cardiac centers.
• Improved Device Durability and Clinical Outcomes
  Modern bioprosthetic valves demonstrate improved anti-calcification treatment and leaflet durability exceeding 15 years in many patient populations. Mechanical valve designs are evolving to reduce anticoagulation requirements.
• Favorable Reimbursement and Structural Heart Programs
  Medicare covers the majority of TAVR and SAVR procedures, while commercial insurers increasingly support broader indications. Structured heart team models have improved procedural safety and outcomes.

Innovation in Focus: Advancements in Valve Technology

Manufacturers are investing heavily in lower-profile delivery systems, repositionable transcatheter valves, and enhanced leaflet biomaterials. Sutureless valves reduce operative time in minimally invasive surgical procedures.

Emerging polymer-based valve materials are under investigation to reduce thrombogenicity and improve durability. US-based clinical trials continue evaluating transcatheter mitral and tricuspid valve replacement systems, expanding the future addressable market.

AI-assisted imaging integration in hybrid ORs is improving procedural planning and valve positioning accuracy, reducing complications such as paravalvular leak.

Recent Developments

FDA approvals for expanded TAVR indications and ongoing TMVR trials are shaping the next phase of market expansion. Structural heart programs are extending into mid-sized cities, reducing geographic disparities.

Conclusion

The US Heart Valve Replacement Devices Market Size & Share is positioned for sustained growth through 2035. Rising degenerative valve disease prevalence, expanding transcatheter technologies, favorable reimbursement, and strong innovation pipelines ensure continued market expansion.

With increasing procedural volumes across all four US regions and ongoing technological advancements, the market remains a cornerstone of structural heart intervention in the United States.

The US Heart Valve Replacement Devices Competitive Landscape includes multinational leaders and emerging innovators:

• Edwards Lifesciences – US leader in TAVR technologies with strong California base.
• Medtronic – Broad surgical and transcatheter portfolio with extensive US hospital penetration.
• Abbott Laboratories – Structural heart solutions including mitral replacement technologies.
• Boston Scientific – Expanding cardiovascular interventional portfolio.
• LivaNova – Surgical valve technologies.
• Artivion – Tissue preservation and valve systems.
• Terumo Cardiovascular – Surgical cardiac support technologies.
• Corcym – Surgical prosthetic valve systems.
• Cook Medical – Interventional cardiology solutions.
• WL Gore & Associates – Cardiovascular biomaterials.
• JenaValve Technology – Transcatheter valve innovator.
• Anteris Technologies – Novel tissue-based valve systems.
• Foldax – Polymer heart valve developer.
• ValveXchange – Bioengineered valve technologies.
• 4C Medical Technologies – Structural heart innovation.
• Neovasc – Transcatheter mitral technologies.
• HighLife Medical – Mitral replacement platform.
• Micro Interventional Devices – Minimally invasive devices.
• Siemens Healthineers – Imaging integration leader.
• GE HealthCare – Cardiac imaging systems.
• Philips Healthcare – Hybrid OR imaging solutions.
• Colibri Heart Valve – Next-generation valve systems.
• CryoLife (Artivion brand) – Tissue-based valve technologies.
• Boston Medical Products – Surgical cardiac tools provider.

• Mechanical Heart Valves
  Mechanical valves remain the preferred choice for younger patients requiring long-term durability. These valves are widely used in tertiary cardiac centers across New York, Illinois, and California. Despite requiring lifelong anticoagulation, their longevity supports steady demand.
• Bioprosthetic (Tissue) Heart Valves
  Bioprosthetic valves dominate surgical replacement procedures in elderly populations. The elimination of lifelong anticoagulation makes them favorable for patients over 65. US adoption continues to increase due to enhanced durability technologies.
• Transcatheter Heart Valves
  Transcatheter valves represent the fastest-growing segment. TAVR procedures account for a growing share of aortic valve replacements nationwide. High procedural volumes are reported in Texas, Florida, and California.
• Sutureless Heart Valves
  Sutureless valves support minimally invasive surgical approaches and reduce cardiopulmonary bypass time. Adoption is rising in advanced cardiac surgery programs.

• Surgical Aortic Valve Replacement (SAVR)
  SAVR remains clinically relevant for complex anatomies and younger patient populations. Major academic hospitals continue to perform high SAVR volumes.
• Surgical Mitral Valve Replacement
  Mitral replacement is performed when repair is not feasible. Volumes are stable across large metropolitan cardiac centers.
• Transcatheter Aortic Valve Replacement (TAVR)
  TAVR dominates procedural growth. US annual TAVR volumes now exceed traditional SAVR in many states.
• Transcatheter Mitral Valve Replacement (TMVR)
  TMVR remains in earlier adoption phases but represents strong long-term growth potential.

• Aortic Valve Replacement
  Aortic replacement accounts for the largest revenue share, driven by high aortic stenosis prevalence.
• Mitral Valve Replacement
  Mitral replacement contributes significant market share due to degenerative and functional mitral regurgitation cases.
• Tricuspid Valve Replacement
  Emerging but growing segment as awareness of tricuspid disease increases.
• Pulmonary Valve Replacement
  Primarily indicated in congenital heart disease, representing a smaller but essential segment.

• Hospitals
  Hospitals dominate due to infrastructure requirements and reimbursement pathways.
• Cardiac Specialty Centers
  High procedural concentration in metropolitan specialty centers.
• Ambulatory Surgical Centers (ASCs)
  Limited but growing role in minimally invasive valve interventions.

West Region

The West region leads due to innovation ecosystems and high healthcare spending. California dominates revenue, supported by major cardiac institutions in Los Angeles, San Diego, and San Francisco. Washington and Colorado report strong TAVR adoption. Arizona and Oregon show steady growth driven by aging populations.

Other West states including Nevada, Utah, and New Mexico are expanding cardiac infrastructure. Alaska and Hawaii maintain smaller but stable markets.

Northeast Region

New York and Massachusetts are among the highest TAVR-performing states nationally. Pennsylvania and New Jersey maintain high surgical replacement volumes. Connecticut and Rhode Island show steady expansion supported by Medicare populations.

South Region

The South is the fastest-growing region. Texas performs one of the highest total valve replacement volumes in the US due to its large population base. Florida’s aging demographics drive significant procedural demand. Georgia and North Carolina are emerging structural heart hubs.

Alabama, Tennessee, and South Carolina show expanding cardiac programs, while Mississippi and Louisiana demonstrate moderate growth supported by federal healthcare funding.

Midwest Region

Illinois and Ohio lead due to established academic cardiac centers. Michigan and Minnesota maintain strong research programs. Indiana and Wisconsin show gradual expansion in minimally invasive procedures.

Rural Midwest states report lower density but steady growth trends.

1. US Heart Valve Replacement Devices Market: Market Introduction & Context

1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis

(What this section provides: Defines the market, clarifies research scope, explains data triangulation methodology, and outlines ecosystem stakeholders influencing the US heart valve replacement landscape.)

2. US Heart Valve Replacement Devices Market: Executive Summary

2.1 Key Insights & Market Snapshot (2025)
2.2 Market Size & CAGR Overview (2025–2035)
2.3 Analyst Perspective
2.4 Market Attractiveness Analysis
2.5 Strategic Growth Highlights

(What this section provides: Summarizes market valuation, growth rate, major performing segments, and strategic investment areas for executive-level decision-making.)

3. US Heart Valve Replacement Devices Market: Market Dynamics & Outlook

3.1 Market Drivers
3.1.1 Rising Prevalence of Aortic Stenosis
3.1.2 Expansion of TAVR & TMVR Programs
3.1.3 Aging US Population
3.1.4 Favorable CMS & Private Reimbursement

3.2 Market Restraints
3.2.1 High Device & Procedure Costs
3.2.2 Infrastructure Requirements
3.2.3 Post-Procedural Complications

3.3 Market Opportunities
3.3.1 Emerging Transcatheter Mitral & Tricuspid Replacement
3.3.2 Expansion into Community Hospitals
3.3.3 AI-Integrated Imaging & Hybrid OR Adoption

3.4 Innovation & Patent Landscape (2020–2025)

(What this section provides: Evaluates growth drivers, challenges, reimbursement influence, competitive intensity, and future opportunities shaping the market.)

4. US Heart Valve Replacement Devices Market: Industry Analysis

4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal

4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Threat of Substitutes
4.2.5 Competitive Rivalry

4.3 Pricing Trend Analysis
4.4 Value Chain Analysis
4.5 Supply Chain Assessment
4.6 Regulatory Framework (FDA & CMS)
4.7 Government Initiatives & Policy Impact
4.8 Impact of Geopolitical & Economic Factors

(What this section provides: Comprehensive macro and micro-environmental assessment of regulatory, competitive, and economic forces influencing industry performance.)

5. US Heart Valve Replacement Devices Market – By Product Type

5.1 Overview
5.2 Market Share Analysis, 2025 & 2035

5.3 Mechanical Heart Valves
5.4 Bioprosthetic (Tissue) Heart Valves
5.5 Transcatheter Heart Valves
5.6 Sutureless Heart Valves

(What this section provides: Revenue distribution and growth analysis across different valve technologies driving replacement procedures.)

6. US Heart Valve Replacement Devices Market – By Procedure Type

6.1 Overview
6.2 Market Share Analysis, 2025 & 2035

6.3 Surgical Aortic Valve Replacement (SAVR)
6.4 Surgical Mitral Valve Replacement
6.5 Transcatheter Aortic Valve Replacement (TAVR)
6.6 Transcatheter Mitral Valve Replacement (TMVR)

(What this section provides: Comparative assessment of surgical versus transcatheter procedure trends and their revenue contributions.)

7. US Heart Valve Replacement Devices Market – By Valve Position

7.1 Overview
7.2 Market Share Analysis, 2025 & 2035

7.3 Aortic Valve Replacement
7.4 Mitral Valve Replacement
7.5 Tricuspid Valve Replacement
7.6 Pulmonary Valve Replacement

(What this section provides: Valve-specific procedural demand trends and position-wise revenue contribution.)

8. US Heart Valve Replacement Devices Market – By End User

8.1 Overview
8.2 Market Share Analysis, 2025 & 2035

8.3 Hospitals
8.4 Cardiac Specialty Centers
8.5 Ambulatory Surgical Centers

(What this section provides: Institutional adoption patterns and infrastructure capacity analysis across care settings.)

9. US Heart Valve Replacement Devices Market – By Geography

9.1 Introduction
9.2 Regional Market Share Analysis, 2025 & 2035

9.3 West Region

9.3.1 Regional Overview & Trends
9.3.2 Market Size & Forecast, 2025–2035
9.3.3 By Product Type
9.3.4 By Procedure Type
9.3.5 By Valve Position
9.3.6 By End User

9.3.7 California
9.3.8 Washington
9.3.9 Colorado
9.3.10 Arizona
9.3.11 Oregon

9.3.12 Others (West Region)
9.3.12.1 Utah
9.3.12.2 Nevada
9.3.12.3 New Mexico
9.3.12.4 Idaho
9.3.12.5 Montana
9.3.12.6 Wyoming
9.3.12.7 Alaska
9.3.12.8 Hawaii

(What this section provides: State-wise revenue forecast, procedural density mapping, structural heart program distribution, and regional growth drivers across Western US.)

9.4 Northeast Region

9.4.1 Regional Overview & Trends
9.4.2 New York
9.4.3 Massachusetts
9.4.4 New Jersey
9.4.5 Pennsylvania
9.4.6 Connecticut

9.4.7 Others (Northeast Region)
9.4.7.1 Maine
9.4.7.2 Vermont
9.4.7.3 New Hampshire
9.4.7.4 Rhode Island
9.4.7.5 Delaware

(What this section provides: Analysis of high-volume structural heart hubs and Medicare-driven procedural expansion across Northeast states.)

9.5 South Region

9.5.1 Regional Overview & Trends
9.5.2 Texas
9.5.3 Florida
9.5.4 Georgia
9.5.5 North Carolina
9.5.6 Tennessee
9.5.7 South Carolina
9.5.8 Alabama

9.5.9 Others (South Region)
9.5.9.1 Mississippi
9.5.9.2 Louisiana
9.5.9.3 Arkansas
9.5.9.4 Kentucky
9.5.9.5 Oklahoma
9.5.9.6 Maryland
9.5.9.7 Virginia
9.5.9.8 West Virginia

(What this section provides: Fastest-growing region insights driven by aging demographics, large population base, and expanding cardiac infrastructure.)

9.6 Midwest Region

9.6.1 Regional Overview & Trends
9.6.2 Illinois
9.6.3 Ohio
9.6.4 Michigan
9.6.5 Minnesota
9.6.6 Indiana
9.6.7 Wisconsin
9.6.8 Missouri

9.6.9 Others (Midwest Region)
9.6.9.1 Iowa
9.6.9.2 Kansas
9.6.9.3 Nebraska
9.6.9.4 North Dakota
9.6.9.5 South Dakota

(What this section provides: Revenue distribution, procedural access expansion, and adoption trends across industrial and rural Midwest states.)

10. US Heart Valve Replacement Devices Market: Competitive Landscape

10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Competitive Benchmarking

10.4 Company Profiles

10.4.1 Edwards Lifesciences
10.4.2 Medtronic
10.4.3 Abbott Laboratories
10.4.4 Boston Scientific
10.4.5 LivaNova
10.4.6 Artivion
10.4.7 Terumo Cardiovascular
10.4.8 Corcym
10.4.9 Cook Medical
10.4.10 WL Gore & Associates
10.4.11 JenaValve Technology
10.4.12 Anteris Technologies
10.4.13 Foldax
10.4.14 ValveXchange
10.4.15 4C Medical Technologies
10.4.16 Neovasc
10.4.17 HighLife Medical
10.4.18 Micro Interventional Devices
10.4.19 Siemens Healthineers
10.4.20 GE HealthCare
10.4.21 Philips Healthcare
10.4.22 Colibri Heart Valve
10.4.23 CryoLife (Artivion Brand)
10.4.24 Boston Medical Products

(What this section provides: Competitive positioning, innovation benchmarking, financial overview, and strategic developments of key industry participants.)

11. US Heart Valve Replacement Devices Market: Future Outlook (2026–2035)

11.1 Scenario Analysis
11.2 Emerging Technologies
11.3 Long-Term Growth Projections
11.4 Investment & Expansion Opportunities

(What this section provides: Forward-looking projections, disruption analysis, and risk-adjusted strategic outlook.)

12. US Heart Valve Replacement Devices Market: Strategic Recommendations

12.1 For Manufacturers
12.2 For Hospitals & Structural Heart Programs
12.3 For Investors
12.4 For New Entrants

(What this section provides: Actionable strategies for stakeholders to optimize growth and competitive positioning.)

13. US Heart Valve Replacement Devices Market: Disclaimer

(What this section provides: Legal notice, liability limitations, and terms governing report usage.)

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Heart Valve Replacement Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Heart Valve Replacement Devices Market: Procedure Type Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 9: US Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 10: US Heart Valve Replacement Devices Market: Valve Position Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Valve Position
TABLE 12: US Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 13: US Heart Valve Replacement Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Heart Valve Replacement Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Heart Valve Replacement Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 21: California Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 22: California Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 25: Washington Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 26: Washington Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 29: Colorado Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 30: Colorado Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 33: Arizona Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 34: Arizona Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 37: Oregon Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 38: Oregon Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 41: West – Others Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 42: West – Others Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 45: New York Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 46: New York Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 49: Massachusetts Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 50: Massachusetts Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 53: New Jersey Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 54: New Jersey Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 61: Connecticut Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 62: Connecticut Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 69: Texas Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 70: Texas Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 73: Florida Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 74: Florida Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 77: Georgia Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 78: Georgia Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 81: North Carolina Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 82: North Carolina Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 85: Tennessee Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 86: Tennessee Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 89: South Carolina Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 90: South Carolina Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 93: Alabama Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 94: Alabama Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 97: South – Others Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 98: South – Others Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 101: Illinois Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 102: Illinois Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 105: Ohio Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 106: Ohio Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 109: Michigan Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 110: Michigan Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 113: Minnesota Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 114: Minnesota Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 117: Indiana Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 118: Indiana Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 121: Wisconsin Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 122: Wisconsin Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 125: Missouri Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 126: Missouri Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Heart Valve Replacement Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Heart Valve Replacement Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Heart Valve Replacement Devices Market, by Valve Position, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Heart Valve Replacement Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)

List of Figures

FIGURE 1: US Heart Valve Replacement Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTEL Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Procedure Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Valve Position Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Valve Position Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region US Heart Valve Replacement Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Heart Valve Replacement Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Heart Valve Replacement Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Heart Valve Replacement Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Heart Valve Replacement Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)